Single agent palliative chemotherapy for end-stage Hodgkin's disease
- 1 September 1982
- Vol. 50 (5) , 829-835
- https://doi.org/10.1002/1097-0142(19820901)50:5<829::aid-cncr2820500504>3.0.co;2-r
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- The consequences of the chemotherapy of Hodgkin's disease: The 10th David A. Karnofsky memorial lectureCancer, 1981
- Curability of Advanced Hodgkin's Disease with ChemotherapyAnnals of Internal Medicine, 1980
- Prolonged Disease-Free Survival in Hodgkin's Disease with MOPP Reinduction After First RelapseAnnals of Internal Medicine, 1979
- Combined modality therapy of Hodgkin's disease.A report on the stanford trialsCancer, 1978
- Treatment of advanced Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide (ABVD) after failure of MOPP therapyCancer, 1978
- Impact of salvage treatment on initial relapses in patients with Hodgkin disease, stages I-IIIBlood, 1978
- Treatment of advanced Hodgkin's disease with B-CAVe following MOPP failureCancer, 1978
- Combination chemotherapy of advanced previously treated Hodgkin's disease with streptozotocin, CCNU, adriamycin and bleomycinMedical and Pediatric Oncology, 1977
- New multiple-agent chemotherapy (B-DOPA) for advanced Hodgkin's diseaseCancer, 1976
- Initial relapses in previously treated Hodgkin's disease.I. Results of second treatmentCancer, 1976